JP6752140B2 - 経口脱感作のための落花生処方物の製造 - Google Patents

経口脱感作のための落花生処方物の製造 Download PDF

Info

Publication number
JP6752140B2
JP6752140B2 JP2016501522A JP2016501522A JP6752140B2 JP 6752140 B2 JP6752140 B2 JP 6752140B2 JP 2016501522 A JP2016501522 A JP 2016501522A JP 2016501522 A JP2016501522 A JP 2016501522A JP 6752140 B2 JP6752140 B2 JP 6752140B2
Authority
JP
Japan
Prior art keywords
peanut
ara
formulation
peanut flour
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016501522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512537A5 (https=
JP2016512537A (ja
Inventor
ウォルサー，ブライアン
ラフ，ハワード，ヴィー．
Original Assignee
アイミューン セラピューティクス，インコーポレイテッド
アイミューン セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6752140(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by アイミューン セラピューティクス，インコーポレイテッド, アイミューン セラピューティクス，インコーポレイテッド filed Critical アイミューン セラピューティクス，インコーポレイテッド
Publication of JP2016512537A publication Critical patent/JP2016512537A/ja
Publication of JP2016512537A5 publication Critical patent/JP2016512537A5/ja
Priority to JP2019034083A priority Critical patent/JP6891205B2/ja
Application granted granted Critical
Publication of JP6752140B2 publication Critical patent/JP6752140B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016501522A 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造 Active JP6752140B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019034083A JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
US61/784,964 2013-03-14
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034083A Division JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Publications (3)

Publication Number Publication Date
JP2016512537A JP2016512537A (ja) 2016-04-28
JP2016512537A5 JP2016512537A5 (https=) 2017-04-20
JP6752140B2 true JP6752140B2 (ja) 2020-09-09

Family

ID=51528061

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016501522A Active JP6752140B2 (ja) 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Country Status (19)

Country Link
US (5) US9198869B2 (https=)
EP (3) EP2968529B1 (https=)
JP (3) JP6752140B2 (https=)
CN (2) CN105101994B (https=)
AU (5) AU2014240404B2 (https=)
BR (1) BR112015021756B1 (https=)
CA (1) CA2903229A1 (https=)
DK (2) DK3482771T3 (https=)
ES (2) ES2940686T3 (https=)
FI (2) FI3482771T3 (https=)
FR (1) FR23C1026I2 (https=)
HU (1) HUE051831T2 (https=)
MX (1) MX2015010315A (https=)
NL (1) NL301236I2 (https=)
NO (1) NO2023027I1 (https=)
PL (1) PL2968529T3 (https=)
PT (1) PT2968529T (https=)
SI (1) SI2968529T1 (https=)
WO (1) WO2014159607A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2014159607A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Manufacture of peanut formulations for oral desensitization
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
AU2015306683B2 (en) 2014-08-25 2021-11-25 Societe Des Produits Nestle S.A. Egg protein formulations and methods of manufacture thereof
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
MA41558B1 (fr) 2015-02-20 2023-02-28 Univ Leland Stanford Junior Compositions d'allergènes mélangés et leurs procédés d'utilisation
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
KR102609841B1 (ko) * 2016-12-05 2023-12-06 리액타 바이오테크 리미티드 경구 식품 유발시험 식사 제제
EP3568027A4 (en) * 2017-01-13 2020-11-11 Aimmune Therapeutics, Inc. WALNUT FLOUR MANUFACTURING PROCESSES AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
AU2017279647B2 (en) 2017-02-15 2022-05-26 Euroimmun Medizinische Labordiagnostika Ag An improved assay for the diagnosis of peanut allergy
NZ760884A (en) 2017-07-18 2023-05-26 Nestle Sa Methods for making mixed allergen compositions
JP7498661B2 (ja) 2017-11-02 2024-06-12 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法の方法
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
CA3087792A1 (en) 2018-01-16 2019-07-25 Tel Hashomer Medical Research Infrastructure And Services Ltd. Treatment and prevention of seed allergies
US11406563B2 (en) 2018-07-27 2022-08-09 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
WO2020037151A1 (en) 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
JP7659494B2 (ja) * 2018-12-17 2025-04-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 卵に対する経口免疫療法のための製剤、製造方法、及び卵アレルギーの治療
CA3123605A1 (en) * 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
CN113507844A (zh) 2019-01-23 2021-10-15 前品牌股份有限公司 制备混合型过敏原组合物的方法
EP3965815A4 (en) 2019-05-10 2023-05-31 Société des Produits Nestlé S.A. METHOD OF IMPROVING THE QUALITY OF LIFE IN A PEANUT ALLERGY PATIENT
ES3038192T3 (en) * 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
BR112022009664A2 (pt) * 2019-11-20 2022-08-16 Nestle Sa Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos
CA3162040A1 (en) * 2019-12-23 2021-07-01 Bronwyn POLLOCK Pharmaceutical compositions
BR112022026945A2 (pt) 2020-07-01 2023-03-07 Nestle Sa Determinação de equipe médica para imunoterapia oral
EP4274609A1 (en) 2021-01-08 2023-11-15 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
CN119365211A (zh) 2022-04-11 2025-01-24 爱尔开-阿贝优公司 花生过敏原组合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) * 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
WO2001039799A2 (en) 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Passive desensitization
EP1272213B1 (en) * 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbial delivery system
MXPA05009079A (es) * 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US7820175B2 (en) 2004-03-19 2010-10-26 Herbal Spring, Llc Herbal therapy for the treatment of food allergy
CN101351191A (zh) * 2005-12-28 2009-01-21 特瓦制药工业有限公司 生物利用率改善的非诺贝特药物制剂
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
JP2012509329A (ja) 2008-11-19 2012-04-19 アバントール パフォーマンス マテリアルズ， インコーポレイテッド 直接圧縮可能で高機能性な顆粒状の微結晶性セルロースベース賦形剤、それらの製造プロセスおよび使用
MX2011006353A (es) 2008-12-19 2011-07-13 Merz Pharma Gmbh & Co Kgaa Derivados de 1-amino-alquilciclohexano para el tratamiento de enfermedades mediadas por mastocitos.
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
UY33472A (es) * 2010-06-30 2012-01-31 Novartis Ag ?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?.
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
ES2936312T3 (es) * 2011-08-31 2023-03-16 Perosphere Tech Inc Métodos para la desensibilización eficaz y rápida de pacientes alérgicos
WO2013087119A1 (en) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
WO2014159607A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Manufacture of peanut formulations for oral desensitization
US9492535B2 (en) * 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
AU2015306683B2 (en) 2014-08-25 2021-11-25 Societe Des Produits Nestle S.A. Egg protein formulations and methods of manufacture thereof
EP3568027A4 (en) 2017-01-13 2020-11-11 Aimmune Therapeutics, Inc. WALNUT FLOUR MANUFACTURING PROCESSES AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
JP7498661B2 (ja) 2017-11-02 2024-06-12 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法の方法

Also Published As

Publication number Publication date
AU2016231523A1 (en) 2016-10-06
CN109125283A (zh) 2019-01-04
US9198869B2 (en) 2015-12-01
CN105101994A (zh) 2015-11-25
SI2968529T1 (sl) 2021-03-31
JP6891205B2 (ja) 2021-06-18
JP2019108357A (ja) 2019-07-04
BR112015021756A2 (pt) 2017-07-18
AU2020202685B2 (en) 2022-01-20
EP2968529B1 (en) 2020-08-05
AU2020202685A1 (en) 2020-05-14
AU2022201858B2 (en) 2024-04-04
AU2016231523B2 (en) 2018-05-31
DK2968529T3 (da) 2020-10-12
DK3482771T3 (da) 2023-03-20
EP3482771B1 (en) 2023-01-18
PL2968529T3 (pl) 2021-04-19
JP7454519B2 (ja) 2024-03-22
CN105101994B (zh) 2018-10-12
NO2023027I1 (no) 2023-07-06
BR112015021756A8 (pt) 2019-11-19
US20140271836A1 (en) 2014-09-18
US20200129378A1 (en) 2020-04-30
FI3482771T3 (fi) 2023-04-03
EP3482771A1 (en) 2019-05-15
MX2015010315A (es) 2016-04-13
US10449118B2 (en) 2019-10-22
AU2022201858A1 (en) 2022-04-07
BR112015021756B1 (pt) 2023-01-10
US11141352B2 (en) 2021-10-12
US20160030289A1 (en) 2016-02-04
CA2903229A1 (en) 2014-10-02
AU2014240404B2 (en) 2016-07-21
JP2021073321A (ja) 2021-05-13
JP2016512537A (ja) 2016-04-28
FR23C1026I2 (fr) 2024-07-26
ES2826224T3 (es) 2021-05-17
HUE051831T2 (hu) 2021-03-29
HK1217660A1 (zh) 2017-01-20
EP3998080A1 (en) 2022-05-18
WO2014159607A1 (en) 2014-10-02
FR23C1026I1 (fr) 2023-10-06
FIC20230022I1 (fi) 2023-07-04
US20180042816A1 (en) 2018-02-15
PT2968529T (pt) 2020-11-10
EP2968529A1 (en) 2016-01-20
AU2014240404A1 (en) 2015-09-17
NL301236I2 (nl) 2025-07-31
US20230120350A1 (en) 2023-04-20
ES2940686T3 (es) 2023-05-10
EP2968529A4 (en) 2016-10-05
AU2018222980A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
JP6891205B2 (ja) 経口脱感作のための落花生処方物の製造
US12016917B2 (en) Peanut formulations and uses thereof
JP7012929B2 (ja) タマゴのタンパク質製剤およびその製造方法
WO2018132733A1 (en) Methods of manufacture of nut flours and formulations for oral immunotherapy
HK40003142A (en) Manufacture of peanut formulations for oral desensitization
HK40008413A (en) Manufacture of peanut formulations for oral desensitization
HK1217660B (zh) 用於口服脱敏的花生制剂的制备
HK40008413B (en) Manufacture of peanut formulations for oral desensitization
US12527860B2 (en) Compositions for immunotherapy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170313

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170313

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171128

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180524

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190227

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190319

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190404

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20190320

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200326

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200818

R150 Certificate of patent or registration of utility model

Ref document number: 6752140

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250